Literature DB >> 18063103

Thrombophilia and adverse pregnancy outcome.

Benjamin Brenner1, Anat Aharon.   

Abstract

This article focuses on the clinical evaluation and management of women who have thrombophilia-related placental vascular complications, including fetal loss, pre-eclampsia, intrauterine fetal growth restriction, and placental abruption. All are major causes of maternal and fetal adverse outcomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18063103     DOI: 10.1016/j.clp.2007.09.002

Source DB:  PubMed          Journal:  Clin Perinatol        ISSN: 0095-5108            Impact factor:   3.430


  3 in total

1.  Comprehensive Evaluation of the Effectiveness and Safety of Placenta-Targeted Drug Delivery Using Three Complementary Methods.

Authors:  Baozhen Zhang; Zhilong Chen; Jinyu Han; Mengxia Li; Nihar R Nayak; Xiujun Fan
Journal:  J Vis Exp       Date:  2018-09-10       Impact factor: 1.355

2.  Pravastatin prevents miscarriages in mice: role of tissue factor in placental and fetal injury.

Authors:  Patricia Redecha; Nico van Rooijen; Donald Torry; Guillermina Girardi
Journal:  Blood       Date:  2009-02-20       Impact factor: 22.113

3.  Genetic risk assessment of thrombophilia in patients with adverse obstetric outcomes.

Authors:  M Fernández Arias; E Mazarico; A Gonzalez; M Muniesa; C Molinet; L Almeida; M D Gómez Roig
Journal:  PLoS One       Date:  2019-02-27       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.